humaglobin human immunglobulin i.v. használatra
human gyógyszergyártó rt. - immunglobulin (humán) -
16%-os human gamma-globulin emberi normál immunglobulin 16%-os steril oldata, i.m. oltásra
human gyógyszergyártó rt. - immunglobulin (humán) -
endobulin human immunglobulin iv. alkalmazásra
baxter (hungary) kft. - immunglobulin (humán) -
octagam human normál immunglobulin g intravénás alkalmazásra
octapharma nordic ab - immunglobulin (humán) -
gammagard s/d iv. immunglobulin
baxter (hungary) kft. - immunglobulin (humán) -
rhogam human rho(d) immunglobulin, ultraszűrt
ortho-clinical diagnostics gmbh - immunglobulin (specifikus) -
micrhogam humán rho(d) immunglobulin, ultraszűrt
ortho-clinical diagnostics gmbh - immunglobulin (specifikus) -
verorab 2,5 ne/0,5 ml por és oldószer szuszpenziós injekcióhoz ampullában
sanofi pasteur sa - a veszettség vírus, wistar veszettség pm/wi38 1503-3m törzs (inaktivált) -
nplate
amgen europe b.v. - romiplosztimot - purpura, trombocitopén, idiopátiás - antihaemorrhagiás - adults:nplate is indicated for the treatment of primary immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. kortikoszteroidok, immunglobulinok). paediatrics:nplate is indicated for the treatment of chronic primary immune thrombocytopenia (itp) in paediatric patients one year of age and older who are refractory to other treatments (e. kortikoszteroidok, immunglobulinok).
idefirix
hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunszuppresszánsok - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.